Designed to run on the company's Sentosa real-time PCR system, the test has been approved for identifying and differentiating Zika in patients.
Early trial of experimental gene-based Zika vaccine indicates it is tolerated and leads to an antibody response.
As gene drive research is being proposed to find a solution to infectious disease outbreaks, some organizations say we must lay an ethical groundwork for its use.
The test is intended for use by blood collection facilities and is not approved for the individual diagnosis of Zika infection.
In Science this week: ancient African genome sequences, Zika virus mutation linked to microcephaly, and more.
In PLOS this week: gene classifier for predicting breast cancer metastases, call for standardized Zika virus reference sequences, and more.
The PCR-based test can simultaneously detect for the Zika virus, all serotypes of the dengue virus, the chikungunya virus, the West Nile virus, and a host gene.
The US Food and Drug Administration yesterday granted emergency use authorization to Thermo Fisher Scientific's TaqPath Zika Virus Kit.
The group will study the potential risks and benefits of using CRISPR/Cas9 to develop gene drive systems for control and manipulation of mosquito populations.
The assay is based on real-time reverse transcriptase PCR that will identify Zika in human serum or urine.
A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.
Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.
In Science this week: CRISPR-based approach for recording cellular events, and more.
A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.